SEC Form 4 · accession 0001453814-18-000120
Medidata Solutions, Inc. · MDSO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Rouven Bergmann
Officer — Chief Financial Officer
Period of report
Sep 4, 2018
Accepted (ET)
Sep 6, 2018 · 4:45 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001453814
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Sep 4, 2018 | M | 20,000 | $53.29 | A | 98,862 | D | |
| Common StockF1,F2 | Sep 4, 2018 | S | 20,000 | $84.24 | D | 78,862 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1,F3 | $53.29 | Sep 4, 2018 | M | 20,000 | A | — | May 13, 2025 | Common Stock | 20,000 | 37,643 | D |
Explanation of responses
- F1The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 26, 2018.
- F2Such transaction was executed in multiple trades at prices ranging from $83.91 to $84.86. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F3The options vested as to 25% of the shares on May 13, 2016 and 1/36th of the remaining options will become exercisable each month thereafter for the next 36 months.